NCT07702292 [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications Status RECRUITING Phase PHASE2
NCT07674615 IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE1
NCT07617753 Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 Status RECRUITING Phase PHASE1/PHASE2
NCT07545460 A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07432633 [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications Status RECRUITING Phase PHASE1/PHASE2
NCT07218809 AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer Status RECRUITING Phase PHASE3
NCT06994195 A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) Status RECRUITING Phase PHASE3
NCT06915025 Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer Status RECRUITING Phase PHASE3
NCT06890338 A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. Status RECRUITING Phase PHASE2
NCT06756035 CT-95 in Advanced Cancers Associated With Mesothelin Expression Status RECRUITING Phase PHASE1
NCT06386887 Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer Status RECRUITING Phase NA
NCT05991752 Health-Economic Evaluation of Early Diagnosis of Epithalial Ovarian Cancer Recurrence Using the ROMA Score: a Prospective Multicenter Randomized Trial Status WITHDRAWN Phase NA
NCT05429970 A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) Status RECRUITING Phase NA
NCT03872947 A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02644369 Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00086567 Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers Status COMPLETED Phase N/A